AAS
IONS icon

Ameritas Advisory Services’s Ionis Pharmaceuticals IONS Stock Holding History

Ameritas Advisory Services’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-87
Closed -$5.69K – 1522
2025
Q3 		$5.69K Sell
87
-59
-40% -$2.88K ﹤0.01% 1807
2025
Q2 		$5.77K Buy
+146
New +$4.78K ﹤0.01% 2196
2023
Q2 		– Sell
-191
Closed -$6.83K – 1540
2023
Q1 		$6.83K Buy
+191
New +$7.17K ﹤0.01% 2045

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Ameritas Advisory Services's IONS Position: Q4 2025 in Review

Ameritas Advisory Services sold out of Ionis Pharmaceuticals (IONS) in Q4 2025, closing a stake of 87 shares — an estimated $5.69K sold.

Ameritas Advisory Services first reported a position in IONS in Q1 2023 and held it in 3 quarters. The position peaked at $6.83K in Q1 2023. 491 funds tracked by Wall St. Rank hold IONS as of Q4 2025.

  • Ameritas Advisory Services reported no remaining Ionis Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Ameritas Advisory Services sold 87 Ionis Pharmaceuticals shares in Q4 2025, an estimated $5.69K.
  • Ameritas Advisory Services first reported a position in Ionis Pharmaceuticals in Q1 2023 and held it in 3 quarters.
  • Ameritas Advisory Services's Ionis Pharmaceuticals position peaked at $6.83K in Q1 2023.
  • 491 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2025.

Based on Ameritas Advisory Services's 13F filing for Q4 2025, filed 4 Feb 2026.